NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Packaged Foods · USD

Niagen Bioscience, Inc. (NAGE) Stock Analysis

Niagen Bioscience, Inc. (NAGE) is a Packaged Foods stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

NAGE

$2.47

−$0.04 (−1.59%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare NAGE with… →

NAGE Key Statistics

As of Oct 21, 2026
Trading
Open
$2.52
Previous Close
$2.51
Day's Range
2.43–2.52
52-Week Range
2.43–7.95
Volume
652.26K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
2.02
Valuation
Market Cap
$195.44M
P/E Ratio
13.00
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.51
EPS (ttm)Profit attributable to each share over the last twelve months.
0.19
Financials (FY)
Revenue (FY)
$129.42M+29.95%
Net Income (FY)
$17.38M+103.30%
Profit marginThe share of revenue left as profit after all costs and taxes.
12.39%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
79.13M
1-Year Return
−67.11%
Dividend and dates
Earnings Date
November 4, 2026
Avg Volume
553.76K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, NAGE closed at $2.47, −67.11% over 1 year.

Niagen Bioscience, Inc. (NAGE) has a market capitalization of $195.44M.

In fiscal 2025, NAGE reported revenue of $129.42M.

NAGE Stock Return by Calendar Year

Niagen Bioscience, Inc. (NAGE) 10-year return: what $10,000 became

1 year
$10,000 $3,289
−67.11%
5 years
$10,000 $3,939
−60.61%
10 years
$10,000 $8,576
−14.24%

If you had invested $10,000 in Niagen Bioscience, Inc. (NAGE) 10 years ago, at the close on October 21, 2016, it would have been worth $8,576 at the close on October 21, 2026: −14.24% in total, −1.52% a year. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−61.16%
2025+19.77%
2024+271.33%
2023−14.88%
2022−55.08%
2021−22.08%
2020+11.37%
2019+25.66%
2018−41.67%
2017+77.64%
2016 (partial year)−18.87%

As of October 21, 2026.

NAGE Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$129.42M$17.38M13.4%
2024$99.60M$8.55M8.6%
2023$83.57M−$4.94M−5.9%
2022$72.05M−$16.54M−23.0%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$129.42M$83.19M$14.30M$17.38M13.4%
2024$99.60M$61.59M$7.73M$8.55M8.6%
2023$83.57M$50.78M−$5.60M−$4.94M−5.9%
2022$72.05M$42.80M−$18.63M−$16.54M−23.0%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

NAGE Valuation vs Packaged Foods Median

Median of 70 stocks
MetricNAGEPackaged Foods medianvs median
P/E13.0014.4710% below
P/S ratio1.510.67127% above
Profit margin12.39%2.27%10.1 pts above

Medians across 70 Packaged Foods stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Niagen Bioscience, Inc. (NAGE) is capitalised at $195.44M on the latest close. It is classified in the Packaged Foods industry, within the Consumer Defensive sector. The company reports 117 employees.

Over the past 52 weeks the price has ranged from $2.43 to $7.95. The most recent close on file for NAGE is $2.47, dated October 21, 2026. That is −$0.04 (−1.59%) against the previous close. The latest close sits 1.86% above that 52-week low.

Financial Health

In fiscal 2025, Niagen Bioscience, Inc. reported revenue of $129.42M. Against the prior fiscal year total of $99.60M, that is a change of +29.95%. The same year closed with net income of $17.38M. That is +103.30% against the prior fiscal year. Profit margin runs at 12.39%. That is 10.1 percentage points above the Packaged Foods median of 2.27%. Trailing earnings per share are 0.19.

Across the 4 fiscal years on file, revenue moves from $72.05M in 2022 to $129.42M in 2025. Of those 4 years, 2 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 13. That is 10.13% below the Packaged Foods median of 14.47. Measured against sales, the shares trade at 1.51 times revenue. On price-to-sales that is 127.44% above the Packaged Foods median of 0.67. The medians here are taken across 70 Packaged Foods companies that report the metric.

Beta against the wider market is reported at 2.02. Daily returns over the trailing 10 years annualize to a volatility of 78.43%. Over the trailing twelve months the total return is −67.11%. Across 10 years the annualized return works out at −1.52%.

Growth & Income

No dividend is on file for NAGE.

So far in 2026 the total return is −61.16%. Across the complete calendar years on file, 2024 returned +271.33% and 2022 returned −55.08%. Of the 9 complete calendar years on file, 5 finished higher.

Peer Comparison

Niagen Bioscience, Inc. (NAGE) operates in the Packaged Foods industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Niagen Bioscience, Inc. NAGE $195.44M 13.0
The Kraft Heinz Company KHC $27.87B —
General Mills, Inc. GIS $17.41B —
Saputo Inc. SAP.TO CA$16.14B 23.7

Market caps are shown in each company's own trading currency, without conversion, and the peers are listed in order of these unconverted figures.

The Packaged Foods industry average P/E ratio is 14.5x. Niagen Bioscience, Inc. trades at a P/E of 13.0.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Packaged Foods Stocks

KHC

The Kraft Heinz Company

$27.87B

 GIS

General Mills, Inc.

$17.41B

 SAP.TO

Saputo Inc.

CA$16.14B

 SJM

The J. M. Smucker Company

$13.65B

 JBS

JBS N.V.

$13.35B

 MKC

McCormick & Company, Incorporated

$12.46B
View all Packaged Foods stocks →

Popular Consumer Defensive Stocks

WMT

Walmart Inc.

$937.46B

 COST

Costco Wholesale Corporation

$442.38B

 KO

The Coca-Cola Company

$398.76B

 PG

The Procter & Gamble Company

$364.29B

 PM

Philip Morris International Inc.

$307.76B
View all Consumer Defensive stocks →

About Niagen Bioscience, Inc.

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulates cellular metabolism; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceutical-grade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products. In addition, it commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient under NIAGEN brand name. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and authorized healthcare practitioners resellers. The company was formerly known as ChromaDex Corporation and changed its name to Niagen Bioscience, Inc. in March 2025. Niagen Bioscience, Inc. was founded in 1999 and is headquartered in Los Angeles, California.

Visit website →